estimated revenue glp-1 drugs Receptor Agonist Market Size & Analysis, 2026-2033 GLP-1R market: A two-horse race,

and the potential to exacerbate social isolation

doi: 10.1016/S0008-6363(02)00809-X

Table 1 presents the GLP-1R agonists currently used in T2D treatment and their reported effects on disease-associated cardiovascular and kidney pathology in long-term human studies

Going forward this provides a valuable yardstick for evaluating the benefits of GLP-1 drugs which have been used since 2005

Ozempic and Mounjaro , for example, are often highlighted in discussions about effective diabetes and weight management treatments

Digital Health & AI: Tech-Supported Models Show Real-World Gains Digital health tools and AI-driven support arent just buzzwordstheyre delivering real results for weight management patients on GLP-1 therapy